pioglitazone; glimepiride
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for pioglitazone; glimepiride, covering 2023-09-13 to 2023-09-13. Get the full timeline:
Most recent: EMA Authorised: Tandemact (pioglitazone;glimepiride) — CHEPLAPHARM Arzneimittel GmbH